259 related articles for article (PubMed ID: 11754355)
1. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
[TBL] [Abstract][Full Text] [Related]
2. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
3. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
4. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
Zhu F; Eckels DD
Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
[TBL] [Abstract][Full Text] [Related]
6. Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.
Pingel S; Weyer S; Galle PR; Löhr HF
J Med Virol; 2002 Apr; 66(4):472-80. PubMed ID: 11857524
[TBL] [Abstract][Full Text] [Related]
7. HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.
Ohira H; Iwasaki M; Takiguchi J; Rai T; Shishido S; Abe K; Takeda J; Tojo J; Sato Y; Kasukawa R
Fukushima J Med Sci; 2002 Dec; 48(2):75-83. PubMed ID: 12680611
[TBL] [Abstract][Full Text] [Related]
8. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
9. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.
Cucchiarini M; Kammer AR; Grabscheid B; Diepolder HM; Gerlach TJ; Grüner N; Santantonio T; Reichen J; Pape GR; Cerny A
Cell Immunol; 2000 Aug; 203(2):111-23. PubMed ID: 11006009
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
Ibe M; Sakaguchi T; Tanaka K; Saito S; Yokota S; Tanaka T; Shimotohno K; Chujoh Y; Shiratori Y; Omata M; Miwa K; Takiguchi M
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
Koziel MJ; Walker BD
Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
[TBL] [Abstract][Full Text] [Related]
13. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
[TBL] [Abstract][Full Text] [Related]
14. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
15. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
[TBL] [Abstract][Full Text] [Related]
16. Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
Giuggio VM; Bonkovsky HL; Smith J; Rothman AL
Virology; 1998 Nov; 251(1):132-40. PubMed ID: 9813209
[TBL] [Abstract][Full Text] [Related]
17. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
19. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
20. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.
Chang KM; Rehermann B; McHutchison JG; Pasquinelli C; Southwood S; Sette A; Chisari FV
J Clin Invest; 1997 Nov; 100(9):2376-85. PubMed ID: 9410918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
